dc.creator | Rocha, EP | |
dc.creator | Francisco, SB | |
dc.creator | Del Bel Cury, AA | |
dc.creator | Cury, JA | |
dc.date | 2003 | |
dc.date | FEB | |
dc.date | 2014-11-16T03:23:04Z | |
dc.date | 2015-11-26T16:19:20Z | |
dc.date | 2014-11-16T03:23:04Z | |
dc.date | 2015-11-26T16:19:20Z | |
dc.date.accessioned | 2018-03-28T23:02:22Z | |
dc.date.available | 2018-03-28T23:02:22Z | |
dc.identifier | Journal Of Oral Rehabilitation. Blackwell Publishing Ltd, v. 30, n. 2, n. 131, n. 138, 2003. | |
dc.identifier | 0305-182X | |
dc.identifier | WOS:000180478400004 | |
dc.identifier | 10.1046/j.1365-2842.2003.01015.x | |
dc.identifier | http://www.repositorio.unicamp.br/jspui/handle/REPOSIP/52599 | |
dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/52599 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/52599 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1267682 | |
dc.description | Some studies have evaluated the salivary levels of mutans streptococci (MS) in removable partial denture (RPD) users. Saliva samples (2.0 mL) were obtained from 31 patients in six periods: (T0): immediately before installation of RPD; (T8): 8 days after T0; (T48): 48 days after T0; (T92): 92 days after T0; (T140): 140 days after T0 and (T189): 189 days after T0. The samples were vortexed and serially diluted from 10(-1) to 10(-6) in 0.05 m phosphate buffer (pH 7.4). From each dilution, 0.025 mL was plated on Mitis Salivarius Bacitracin (MSB). The plates were incubated in 5% CO2 at 37 degreesC for 72 h. There was an increase (t -test, P < 0.05) in the number of MS between periods T0 and T48 (mean/s.d., CFU mL(-1) of saliva): T0: 2.26/4.43 x 10(6) and T48: 0.47/1.48 x 10(8) . After this, intensive treatment with CHX was accomplished in 29 patients. Saliva samples were obtained after treatment in four periods: (T24 h): 24 h after T0; (T14): 14 days after T24 h; (T28): 28 days after T24 h, and (T63): 63 days after T24 h. The number of MS in saliva did not decrease (t -test, P > 0.05). A new CHX formulation was applied in 15 patients. Saliva samples were obtained in periods: (T0): before new CHX application; (T24 h): 24 h after T0 and (T82): 82 days after T0. The new CHX reduced MS levels in saliva: (mean/s.d., CFU mL(-1) of saliva): T0: 6.64/8.47 x 10(6) and T24 h: 3.2/4.27 x 10(5) (sign rank, P < 0.05). In conclusion, there was a significant increase in the number of MS in saliva after the installation of RPD. The intensive treatment with a properly formulated CHX was effective in the reduction of MS, between 24 h and 82 days after its application. | |
dc.description | 30 | |
dc.description | 2 | |
dc.description | 131 | |
dc.description | 138 | |
dc.language | en | |
dc.publisher | Blackwell Publishing Ltd | |
dc.publisher | Oxford | |
dc.publisher | Inglaterra | |
dc.relation | Journal Of Oral Rehabilitation | |
dc.relation | J. Oral Rehabil. | |
dc.rights | fechado | |
dc.source | Web of Science | |
dc.subject | removable partial denture | |
dc.subject | saliva | |
dc.subject | mutans streptococci | |
dc.subject | chlorhexidine | |
dc.subject | Chlorhexidine Gel Treatment | |
dc.subject | Dental Plaque | |
dc.subject | Lactobacilli | |
dc.subject | Prevalence | |
dc.subject | Surfaces | |
dc.subject | Varnish | |
dc.title | Longitudinal study of the influence of removable partial denture and chemical control on the levels of Streptococcus mutans in saliva | |
dc.type | Artículos de revistas | |